Tsuneaki Yoshinaga Selected Research

Tsuneaki Yoshinaga Research Topics

23	Amyloidosis 09/2022 - 01/2015
5	Immunoglobulin Light-chain Amyloidosis 02/2021 - 03/2016
3	Amyloid Plaque 05/2021 - 04/2019
3	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 02/2021 - 04/2016
2	Hepatomegaly 05/2021 - 02/2021
2	Transthyretin-Related Hereditary Amyloidosis 07/2020 - 04/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2021
1	Renal Insufficiency (Renal Failure) 05/2021
1	Rare Diseases (Rare Disease) 05/2021
1	Liver Failure 05/2021
1	Male Infertility (Male Sterility) 05/2021
1	Neoplasms (Cancer) 02/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2020
1	Cytopenia 07/2020
1	Rheumatic Diseases (Rheumatism) 07/2020
1	Plasma Cell Neoplasms 07/2020
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2020
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2020
1	Optic Nerve Diseases (Optic Neuropathy) 11/2019
1	Orthostatic Hypotension (Postural Hypotension) 03/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Rupture 03/2017
1	Spinal Cord Diseases 11/2016
1	Cerebrotendinous Xanthomatosis 11/2016
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2015
1	familial visceral Amyloidosis 01/2015

17	Amyloid (Amyloid Fibrils)IBA 03/2022 - 12/2015
10	Prealbumin (Transthyretin)IBA 09/2022 - 04/2016
4	Proteins (Proteins, Gene)FDA Link 05/2021 - 12/2015
3	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2020 - 08/2016
3	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 12/2020 - 01/2018
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2021 - 02/2021
2	Amyloidogenic ProteinsIBA 04/2021 - 03/2016
2	Fibrinogen (Factor I)FDA Link 01/2018 - 01/2015
1	Tolcapone (Tasmar)FDA Link 09/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2022
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 04/2021
1	AntibodiesIBA 04/2021
1	Glucagon (Glukagon)FDA Link 03/2021
1	Dihydrotachysterol (AT 10)IBA 02/2021
1	Technetium Tc 99m PyrophosphateIBA 12/2020
1	B-Cell Activating FactorIBA 11/2020
1	LigandsIBA 11/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020
1	Rituximab (Mabthera)FDA Link 07/2020
1	GlucocorticoidsIBA 07/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2020
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020
1	nusinersenIBA 01/2020
1	Immunoglobulin G (IgG)IBA 11/2019
1	LactoferrinIBA 04/2019
1	diphosphoric acid (pyrophosphoric acid)IBA 03/2019
1	tafamidisIBA 01/2019
1	Amino Acids FDA Link 01/2018
1	Congo RedIBA 01/2018
1	Chenodeoxycholic Acid (Chenix)FDA Link 11/2016
1	LipidsIBA 11/2016
1	Coenzyme A (CoA)IBA 11/2016
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 11/2016